SHIRE PHARMACEUTICAL DEVELOPMENT INC. et al v. AMNEAL PHARMACEUTICALS LLC et al, 1:15-cv-02865, No. 221-3 (D.N.J. Apr. 3, 2017) (2024)

`

`Case 1:15-cv-02865-RBK-JS Document 221-3 Filed 04/03/17 Page 2 of 3 PageID: 5751
`
`pursuant to 101.1(c) of the Local Rules of the United States District Court for the District of New
`
`Jersey, for admission
`
`to
`
`this Court pro hac vice for
`
`the purpose of representing
`
`defendants/counterclaim plaintiffs, Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of
`
`New York, LLC, Amneal Pharmaceuticals Co. (I) Pvt. Ltd., and Amneal Life Sciences Pvt. Ltd.,
`
`(collectively “Amneal”).
`
`
`
`2.
`
`I received a Juris Doctor from the University of Maryland School of Law in 2011
`
`and a Bachelor of Science in Engineering in Chemical Engineering from the University of
`
`Michigan in 2008.
`
`
`
`3.
`
`I was admitted to the District of Columbia Bar in 2012. I am also admitted to the
`
`Maryland State Bar and the United States Patent and Trademark Office.
`
`4.
`
`5.
`
`6.
`
`No disciplinary proceedings are pending against me in any jurisdiction.
`
`No discipline has been previously imposed against me in any jurisdiction.
`
`The names and addresses of the official or office maintaining the roll of the
`
`members of each bar to which I am a member are as follows:
`
`District of Columbia
`Court of Appeals
`Committee on Admissions/CGS
`430 E. Street, NW
`Room 123
`Washington, D.C. 20001
`
`Clerk, Court of Appeals
`Maryland Court of Appeals
`Robert C. Murphy Courts of Appeal Building
`361 Rowe Blvd.
`Annapolis, Maryland 21401
`
`United States Patent and Trademark Office
`600 Dulany Street
`Alexandria, Virginia 22314
`
`2
`
`
`
`
`
`
`
`

`

`Case 1:15-cv-02865-RBK-JS Document 221-3 Filed 04/03/17 Page 3 of 3 PageID: 5752
`Case 1:15-cv-02865-RBK-JS Document 221-3 Filed 04/03/17 Page 3 of 3 PageID: 5752
`
`7.
`
`Amneal retained affiant and Maddox Edwards, PLLC,
`
`to defend against the
`
`claims brought by plaintiffs, Shire Development LLC, Shire Pharmaceutical Development, Inc.,
`
`Cosmo Technologies Limited, and Nogra Pharma Limited.
`
`8.
`
`I am associated in the litigation of this action with Gregory D. Miller of Rivkin
`
`Radler LLP, 21 Main Street, Suite 158, Court Plaza South, West Wing, First Floor, Hackensack,
`
`New Jersey 07601, who is admitted to practice in this Court and in the State of New Jersey, and
`
`who is counsel of record for Amneal.
`
`I am thus associated in this matter with a New Jersey
`
`counsel of record as required by Rule 1:21-2(a)(1).
`
`9.
`
`I agree that I shall abide by the rules governing this Court and am subject to
`
`disciplinary action and the jurisdiction of this Court and the New Jersey State Bar in all respects
`
`as if I were a regularly admitted and licensed member of the Bar of the State of New Jersey in
`
`good/ standing.
`
`10.
`
`I will notify the Court immediately of any matter affecting my standing at the Bar
`
`of any other Court.
`
`11..
`
`I agree that I will make the required payment to the Clerk of the United States
`
`District Court as provided by Local Civil Rule 101 .1(c)(3).
`
`12.
`
`I agree to have all pleadings, briefs, and other papers filed with the Court signed
`
`by Gregory D. Miller or another attorney from the New Jersey office of Rivkin Radler LLP.
`
`13.
`
`I agree that I will otherwise comply with Local Civil Rule 101.1(0).
`
`I declare under penalty of perjury that the foregoing is true and correct.
`Dated: April 3, 2017 @
`
`Kaveh V. Saba
`
`